Statins for acute coronary syndrome
20 results
1 - 20Statins for acute coronary syndrome
Statins for acute coronary syndrome Stable (no update expected for reasons given in 'What's new')
Acute coronary syndrome and myocardial infarction
Coronary heart disease
Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease New search for studies and content updated (conclusions changed)
PSK9 inhibitor alirocumab reduces nonfatal MI in patients after acute coronary syndrome, but at high cost (ODYSSEY OUTCOMES)
Intensive versus moderate statin therapy
Better medication adherence with intervention; clinical outcomes unchanged
Lipid lowering is beneficial for secondary prevention but not primary prevention in patients 75 years and older
Routine or selective invasive strategy for acute coronary syndrome
Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events: Cochrane systematic review
Risk of stroke after TIA is 2.8% at 1 month and 5.1% at 1 year
Overview of new ACC/AHA lipid guidelines: here we go again